US4093610A
(en)
|
1977-01-31 |
1978-06-06 |
American Home Products Corporation |
Process for producing triglycyl-lysine vasopressin and intermediates therefor
|
US4108846A
(en)
|
1977-02-01 |
1978-08-22 |
Hoffmann-La Roche Inc. |
Solid phase synthesis with base N alpha-protecting group cleavage
|
US4169141A
(en)
|
1978-01-30 |
1979-09-25 |
Shering Corporation |
1-Peptidyl derivatives of di-O-aminoglycosyl-1,3-diaminocyclitol antibacterial agents
|
US6005071A
(en)
|
1987-01-23 |
1999-12-21 |
Merrell Pharmaceuticals Inc. |
Anticoagulant peptides
|
US5789540A
(en)
|
1987-01-23 |
1998-08-04 |
Merrell Pharmaceuticals Inc. |
Anticoagulant peptides
|
US6239101B1
(en)
|
1989-07-05 |
2001-05-29 |
Oklahoma Medical Research Foundation |
Thrombin binding polypeptides
|
US5196404B1
(en)
|
1989-08-18 |
1996-09-10 |
Biogen Inc |
Inhibitors of thrombin
|
US5240913A
(en)
|
1989-08-18 |
1993-08-31 |
Biogen, Inc. |
Inhibitors of thrombin
|
CA2067224C
(en)
|
1989-12-01 |
2001-02-13 |
Manfred Kurfuerst |
Hirudin/polyalkylene glycol conjugates
|
US5624822A
(en)
|
1989-12-22 |
1997-04-29 |
Basf Aktiengesellschaft |
Hirudin fusion proteins and preparation of hirudin
|
CA2035917C
(en)
|
1990-02-13 |
2001-10-02 |
John L. Krstenansky |
Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
|
DE4016596A1
(de)
|
1990-05-23 |
1991-11-28 |
Hoechst Ag |
Ein neues kupplungsreagenz fuer die peptidsynthese
|
US6060451A
(en)
|
1990-06-15 |
2000-05-09 |
The National Research Council Of Canada |
Thrombin inhibitors based on the amino acid sequence of hirudin
|
US5574012A
(en)
|
1990-07-24 |
1996-11-12 |
Merrell Pharmaceuticals Inc. |
Analogs of hirudin having anti-platelet activity
|
EP0511393B1
(en)
|
1990-11-08 |
1996-07-31 |
Japan Energy Corporation |
Hirudine mutant, production thereof, anticoagulant, secretory vector, microorganism transformed by said vector, and production of product from said microorganism
|
US5242810A
(en)
|
1990-12-07 |
1993-09-07 |
Biogen, Inc. |
Bifunctional inhibitors of thrombin and platelet activation
|
EP0570428B1
(en)
|
1991-02-04 |
1998-12-16 |
Akzo Nobel N.V. |
FACTOR IIa INHIBITORS
|
DE4103649A1
(de)
|
1991-02-07 |
1992-08-13 |
Basf Ag |
Neue antikoagulatorisch wirksame peptide
|
ES2141102T3
(es)
*
|
1991-02-08 |
2000-03-16 |
Diatide Inc |
Polipeptidos marcados con tecnecio-99m para la generacion de imagenes.
|
US5767235A
(en)
|
1991-03-05 |
1998-06-16 |
Nippon Mining Company Limited |
Anticoagulant hirudin variants and methods for their production
|
US6514730B1
(en)
|
1991-03-21 |
2003-02-04 |
Consortium für elektrochemische Industrie GmbH |
Secretion of hirudin derivatives
|
GB9112825D0
(en)
|
1991-06-14 |
1991-07-31 |
Ici Plc |
Process for making peptides
|
US5837808A
(en)
|
1991-08-20 |
1998-11-17 |
Baxter International Inc. |
Analogs of hirudin
|
GB9118669D0
(en)
|
1991-08-30 |
1991-10-16 |
Univ Southampton |
Preparation of peptides by a soliphase synthesis and intermediates therefor
|
DE4209110A1
(de)
|
1991-11-26 |
1993-05-27 |
Basf Ag |
Neue thrombininhibitorische proteine aus landblutegeln
|
DE4140381A1
(de)
*
|
1991-12-07 |
1993-06-09 |
Hoechst Ag, 6230 Frankfurt, De |
Neue synthetische isohirudine mit verbesserter stabilitaet
|
US5371184A
(en)
|
1992-02-05 |
1994-12-06 |
Mallinckrodt Medical, Inc. |
Radiolabelled peptide compounds
|
FR2687681B1
(fr)
|
1992-02-20 |
1995-10-13 |
Transgene Sa |
Conjugues polyethyleneglycol-hirudine, leur procede de preparation et leur emploi pour le traitement des thromboses.
|
GB9209032D0
(en)
|
1992-04-25 |
1992-06-10 |
Ciba Geigy Ag |
New peptide derivatives
|
US5968476A
(en)
|
1992-05-21 |
1999-10-19 |
Diatide, Inc. |
Technetium-99m labeled peptides for thrombus imaging
|
CN1088836A
(zh)
*
|
1992-12-30 |
1994-07-06 |
中国科学院生物物理研究所 |
重组水蛭素及其复合物用于制备预防和治疗血栓病药物
|
EP0684830B1
(en)
|
1993-02-12 |
1999-06-16 |
Corvas International, Inc. |
Inhibitors of thrombosis
|
US5656600A
(en)
|
1993-03-25 |
1997-08-12 |
Corvas International, Inc. |
α-ketoamide derivatives as inhibitors of thrombosis
|
DE4310632A1
(de)
|
1993-04-01 |
1994-10-06 |
Merck Patent Gmbh |
Lineare Adhäsionsinhibitoren
|
IT1265023B1
(it)
|
1993-04-16 |
1996-10-28 |
Dev Biotechnological Processes |
Inibitori della trombina, loro preparazione ed uso per applicazioni terapeutiche, profilattiche e diagnostiche
|
US5443827A
(en)
|
1993-05-03 |
1995-08-22 |
President And Fellows Of Harvard College |
Fibrin-targeted inhibitors of thrombin
|
DE69432983T2
(de)
|
1993-06-11 |
2004-04-29 |
Merrell Pharmaceuticals Inc., Cincinnati |
Trifunktionelle antithrombin-und antiplättchenpeptide
|
US5457177A
(en)
|
1993-06-16 |
1995-10-10 |
Merck & Co., Inc. |
Thrombin receptor radioligands
|
DE4323754C1
(de)
|
1993-07-15 |
1994-12-01 |
Gruenenthal Gmbh |
Bifunktionelle Urokinasevarianten mit verbesserten fibrinolytischen Eigenschaften und thrombinhemmender Wirkung
|
EP0710228B1
(en)
|
1993-07-19 |
1998-01-21 |
Resolution Pharmaceuticals Inc. |
Hydrazino-type radionuclide chelators having an n 3?s configuration
|
US5972648A
(en)
|
1993-09-28 |
1999-10-26 |
Japan Energy Corporation |
Hirudin analogs, methods of manufacture thereof and anticoagulant compositions having these as active ingredients
|
US5449761A
(en)
|
1993-09-28 |
1995-09-12 |
Cytogen Corporation |
Metal-binding targeted polypeptide constructs
|
FR2710917B1
(fr)
|
1993-10-07 |
1995-11-24 |
Adir |
Nouveaux dérivés de peptides thérapeutiquement actifs dans la cascade de coagulation sanguine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
|
ES2153433T3
(es)
|
1993-10-25 |
2001-03-01 |
Ca Nat Research Council |
Inhibidores de trombina bivalentes.
|
US7060484B1
(en)
|
1993-11-12 |
2006-06-13 |
Gilead Sciences, Inc. |
Polypeptides and coagulation therapy
|
US6156540A
(en)
|
1993-12-22 |
2000-12-05 |
Human Genome Sciences, Inc. |
Thrombin inhibitor
|
DE4404168A1
(de)
|
1994-02-10 |
1995-08-17 |
Hoechst Ag |
Hirudinderivate und Verfahren zu deren Herstellung
|
US6335160B1
(en)
|
1995-02-17 |
2002-01-01 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
US5662885A
(en)
|
1994-07-22 |
1997-09-02 |
Resolution Pharmaceuticals Inc. |
Peptide derived radionuclide chelators
|
US5759542A
(en)
|
1994-08-05 |
1998-06-02 |
New England Deaconess Hospital Corporation |
Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases
|
KR0141651B1
(ko)
|
1994-09-07 |
1998-06-15 |
강재헌 |
금속이온 친화성 크로마토그라피를 이용한 히루딘의 정제방법
|
DE4440892A1
(de)
|
1994-11-17 |
1996-05-23 |
Gruenenthal Gmbh |
Proteine mit fibrinolytischen und gerinnungshemmenden Eigenschaften
|
DE4442665A1
(de)
|
1994-11-30 |
1996-06-05 |
Gruenenthal Gmbh |
Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften
|
US5747453A
(en)
|
1995-06-06 |
1998-05-05 |
Alza Corporation |
Method for increasing the electrotransport flux of polypeptides
|
US5817758A
(en)
|
1995-06-07 |
1998-10-06 |
Terrapin Technologies, Inc. |
P-nitrobenzyl side-chain protection for solid-phase synthesis
|
US5767078A
(en)
|
1995-06-07 |
1998-06-16 |
Johnson; Dana L. |
Agonist peptide dimers
|
DE69627191T2
(de)
|
1995-06-09 |
2004-01-08 |
The Regents Of The University Of Michigan, Ann Arbor |
Bradikininanaloge als selektive thrombininhibitoren
|
IL119466A
(en)
|
1995-11-03 |
2001-08-26 |
Akzo Nobel Nv |
Thrombin inhibitors, their preparation and pharmaceutical compositions containing them
|
US5910481A
(en)
|
1995-11-13 |
1999-06-08 |
Immuno Ag |
Hybrid proteins with modified activity
|
US6333189B1
(en)
|
1996-06-06 |
2001-12-25 |
Alza Corporation |
Method of making an electrotransport device
|
AU723268B2
(en)
|
1996-09-09 |
2000-08-24 |
Zealand Pharma A/S |
Improved solid-phase peptide synthesis and agent for use in such synthesis
|
US7176282B1
(en)
|
1996-09-09 |
2007-02-13 |
Zealand Pharma A/S |
Solid-phase peptide synthesis and agent for use in such synthesis
|
US6265204B1
(en)
|
1997-01-17 |
2001-07-24 |
Genencor International, Inc. |
DNA sequences, vectors, and fusion polypeptides for secretion of polypeptides in filamentous fungi
|
US5986065A
(en)
|
1997-03-10 |
1999-11-16 |
Sunol Molecular Corporation |
Antibodies for inhibiting blood coagulation and methods of use thereof
|
US6077825A
(en)
|
1997-03-13 |
2000-06-20 |
Auburn University |
Antithrombin protein and DNA sequences from black fly
|
GB9708918D0
(en)
|
1997-05-01 |
1997-06-25 |
Ppl Therapeutics Scotland Ltd |
Methods
|
JP4394279B2
(ja)
|
1998-03-09 |
2010-01-06 |
ジーランド ファーマ アクティーゼルスカブ |
酵素加水分解に対する傾向が減少した薬理学的に活性なペプチド複合体
|
US6281331B1
(en)
|
1998-03-23 |
2001-08-28 |
Trimeris, Inc. |
Methods and compositions for peptide synthesis
|
US6451992B1
(en)
|
1998-08-20 |
2002-09-17 |
Auburn University |
Antithrobin nucleotides and proteins from horn fly
|
TR200102912T2
(tr)
|
1999-04-09 |
2002-03-21 |
Basf Ag. |
Trombin ihtibitrlerinin n ilalarì.
|
ES2154590B1
(es)
|
1999-05-20 |
2001-11-01 |
Lipotec Sa |
Procedimiento de sintesis de peptidos en fase solida
|
US6544750B1
(en)
|
1999-08-17 |
2003-04-08 |
Thromgen, Inc. |
Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1
|
CA2340461A1
(en)
|
2000-03-30 |
2001-09-30 |
University Of Manitoba |
Hirulog-like peptide and gene therapy
|
US6506761B1
(en)
|
2000-04-14 |
2003-01-14 |
Corvas International, Inc. |
Substituted hydrazinyl heteroaromatic inhibitors of thrombin
|
JP2002112782A
(ja)
|
2000-10-04 |
2002-04-16 |
Ajinomoto Co Inc |
抗血栓活性を有する蛋白質及びその製造法
|
DE10102878A1
(de)
|
2001-01-23 |
2002-08-01 |
Haemosys Gmbh |
Oligo- oder Polyalkylengekoppelte Thrombininhibitoren
|
WO2002079278A1
(en)
|
2001-03-30 |
2002-10-10 |
Mayo Foundation For Medical Education And Research |
Efficient methods for solid phase synthesis using trityl chloride resins
|
WO2002100337A2
(en)
|
2001-06-08 |
2002-12-19 |
Emory University |
Antithrombotic thrombin variants
|
US6703364B2
(en)
|
2001-07-23 |
2004-03-09 |
Cleveland State University |
Thrombin generation inhibitors
|
WO2003022873A1
(de)
|
2001-09-10 |
2003-03-20 |
Novel Science International Gmbh |
Organische verbindungen mit biologischer wirkung als thrombinhemmer und ihre verwendung
|
GB0123262D0
(en)
|
2001-09-27 |
2001-11-21 |
Adprotech Ltd |
Polymeric compounds
|
KR100718431B1
(ko)
|
2001-11-27 |
2007-05-14 |
주식회사 유앤비케미칼 |
트리틸기가 도입된 폴리스티렌 수지의 제조 방법
|
US7794693B2
(en)
|
2002-03-01 |
2010-09-14 |
Bracco International B.V. |
Targeting vector-phospholipid conjugates
|
WO2003084983A1
(fr)
|
2002-04-11 |
2003-10-16 |
Daiichi Suntory Pharma Co., Ltd. |
Procede de production d'un peptide modifie
|
DE60309019T2
(de)
|
2002-05-03 |
2007-05-16 |
Avecia Ltd., Blackley |
Verfahren zur herstellung von peptidamiden durch seitenkettenanknüpfung an einer festphase
|
US6875893B2
(en)
|
2002-05-23 |
2005-04-05 |
Cephalon, Inc. |
Preparations of a sulfinyl acetamide
|
CA2496739A1
(en)
|
2002-08-26 |
2004-03-04 |
A & Pep Inc. |
Method for synthesizing peptides
|
KR100613945B1
(ko)
|
2002-12-20 |
2006-08-22 |
에프. 호프만-라 로슈 아게 |
고상 결합된 클로로트라이틸 클로라이드 수지의 재활용방법
|
DE10301255A1
(de)
|
2003-01-15 |
2004-07-29 |
Cpi Creative Pharma International Gmbh |
Organische Verbindungen mit biologischer Wirkung als Thrombinhemmer und ihre Verwendung
|
WO2004076484A1
(en)
|
2003-02-27 |
2004-09-10 |
National Research Council Of Canada |
Peptide inhibitors of thrombin as potent anticoagulants
|
US7074765B2
(en)
|
2003-05-01 |
2006-07-11 |
The Regents Of The University Of Michigan |
Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
|
US7393920B2
(en)
|
2003-06-23 |
2008-07-01 |
Cem Corporation |
Microwave-assisted peptide synthesis
|
EP1636267A2
(en)
|
2003-06-26 |
2006-03-22 |
MERCK PATENT GmbH |
Modified hirudin proteins and t-cell epitopes in hirudin
|
DE602004031736D1
(de)
|
2003-07-04 |
2011-04-21 |
Lonza Ag |
Verbessertes verfahren für festphasensynthese
|
US7135534B2
(en)
|
2003-07-24 |
2006-11-14 |
Rajiv Gandhi Centre For Biotechnology |
Polymer support for solid phase peptide synthesis and process for preparation thereof
|
GB0318205D0
(en)
|
2003-08-02 |
2003-09-03 |
Albachem Ltd |
Synthetic method
|
ATE376556T1
(de)
|
2003-12-31 |
2007-11-15 |
Hoffmann La Roche |
Verfahren zur peptidsynthese unter verwendung einer reduzierten menge an entschützungsmittel
|
US20080025966A1
(en)
|
2004-01-30 |
2008-01-31 |
Currie Mark G |
Methods And Compositions For The Treatment Of Gastrointestinal disorders
|
US7795205B2
(en)
|
2004-04-12 |
2010-09-14 |
Canyon Pharmaceuticals, Inc. |
Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
|
EP1600455A1
(en)
|
2004-05-28 |
2005-11-30 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Preparation of solid phase bound peptides or PNAs
|
ATE510013T1
(de)
|
2004-06-23 |
2011-06-15 |
Ca Nat Research Council |
Verfahren und verwendungen von linker enthaltenden polypeptidliganden
|
EP1776588A1
(en)
|
2004-07-12 |
2007-04-25 |
Applera Corporation |
Mass tags for quantitative analyses
|
WO2006102069A2
(en)
|
2005-03-17 |
2006-09-28 |
Microbia, Inc. |
Methods and compositions for the treatment of hypertension and gastrointestinal disorders
|
EP2119725A1
(en)
|
2005-05-03 |
2009-11-18 |
Novetide Ltd. |
Methods for the production of leuprolide
|
US7879792B2
(en)
|
2005-06-02 |
2011-02-01 |
The Regents Of The University Of Michigan |
Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
|
EP1805204A2
(en)
|
2005-09-14 |
2007-07-11 |
Novetide Ltd. |
Process for production of bivalirudin
|
EP1966388B1
(en)
|
2005-12-09 |
2013-08-07 |
Bracco Suisse SA |
Targeting vector-phospholipid conjugates
|
US8314208B2
(en)
|
2006-02-10 |
2012-11-20 |
Cem Corporation |
Microwave enhanced N-fmoc deprotection in peptide synthesis
|
CN101033249B
(zh)
|
2006-03-10 |
2011-05-11 |
周逸明 |
固相多肽合成比筏芦定的制备方法
|
US20080096819A1
(en)
|
2006-05-02 |
2008-04-24 |
Allozyne, Inc. |
Amino acid substituted molecules
|
CA2651070A1
(en)
|
2006-05-03 |
2007-11-15 |
Mallinckrodt Inc. |
Composition and method for the release of protected peptides from a resin
|
CN101516903B
(zh)
|
2006-07-21 |
2014-01-01 |
百帝森萨股份公司 |
用于制造肽的方法
|
WO2008057683A2
(en)
|
2006-10-03 |
2008-05-15 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates
|
US20100168443A1
(en)
|
2006-11-02 |
2010-07-01 |
University Of Virginia Patent Foundation |
Ethoid-Containing Compounds, Methods for Preparing Ethoid-Containing Compounds, and Methods of Use
|
IE20060841A1
(en)
|
2006-11-21 |
2008-05-28 |
Ipsen Mfg Ireland Ltd |
Boc and fmoc solid phase peptide synthesis
|
WO2008073670A2
(en)
|
2006-12-08 |
2008-06-19 |
Millennium Pharmaceuticals, Inc. |
Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor
|
WO2008071081A1
(zh)
|
2006-12-15 |
2008-06-19 |
Institute Of Radiation Medicine, Academy Of Military Medical Sciences, Pla |
低出血抗凝血融合蛋白的制备及其应用
|
CN101245110B
(zh)
|
2007-02-16 |
2010-09-15 |
鲁南制药集团股份有限公司 |
重组中性粒细胞抑制因子和水蛭原嵌合蛋白及其药物组合物
|
EP2057183A2
(en)
|
2007-03-01 |
2009-05-13 |
Novetide Ltd. |
High purity peptides
|
GB0711779D0
(en)
|
2007-06-18 |
2007-07-25 |
Univ Singapore |
Thrombin inhibitor
|
US8206967B2
(en)
|
2007-07-06 |
2012-06-26 |
Medimmune Limited |
Method for production of recombinant human thrombin
|
JP5515738B2
(ja)
|
2007-07-25 |
2014-06-11 |
味の素株式会社 |
ジベンゾフルベン誘導体の淘汰方法
|
CN101372512B
(zh)
|
2007-08-23 |
2011-03-23 |
中国人民解放军军事医学科学院生物工程研究所 |
一类抗凝血多肽及其用途
|
US20090062511A1
(en)
|
2007-09-05 |
2009-03-05 |
Raghavendracharyulu Venkata Palle |
Process for the preparation of bivalirudin and its pharmaceutical compositions
|
CN102027005A
(zh)
|
2008-05-15 |
2011-04-20 |
诺沃-诺迪斯克有限公司 |
通过固相合成制备的肽的纯化
|
US7582727B1
(en)
|
2008-07-27 |
2009-09-01 |
The Medicinces Company |
Pharmaceutical formulations of bivalirudin and processes of making the same
|
US7598343B1
(en)
|
2008-07-27 |
2009-10-06 |
The Medicines Company |
Pharmaceutical formulations of bivalirudin and processes of making the same
|
WO2010016551A1
(ja)
|
2008-08-06 |
2010-02-11 |
味の素株式会社 |
ジベンゾフルベンの除去方法
|
KR20110056536A
(ko)
|
2008-09-03 |
2011-05-30 |
시노팜 타이완 리미티드 |
프람린티드의 제조 방법
|
US20110288235A1
(en)
|
2008-09-03 |
2011-11-24 |
Scinopharm Taiwan Ltd. |
Process for the Preparation of Pramlintide
|
WO2010054503A1
(zh)
|
2008-11-17 |
2010-05-20 |
中国人民解放军军事医学科学院生物工程研究所 |
抗凝血多肽及其应用
|
JP5730781B2
(ja)
|
2008-12-29 |
2015-06-10 |
ロンザ・ブレーヌ・エスエーLonza Braine Sa |
ビバリルジンの製造方法
|
CN101475631B
(zh)
|
2009-01-08 |
2011-08-17 |
苏州中科天马肽工程中心有限公司 |
比伐卢定的液相合成方法
|
US20110160431A1
(en)
|
2009-04-06 |
2011-06-30 |
Novetide, Ltd. |
Production of peptides containing poly-gly sequences using fmoc chemistry
|
GB0907698D0
(en)
|
2009-05-05 |
2009-06-10 |
Univ Singapore |
Method of modifying serine protease inhibitors
|
CN101555274B
(zh)
|
2009-05-15 |
2013-08-21 |
海南双成药业股份有限公司 |
一种多肽固相合成比法卢定粗品的制备方法
|
US7803762B1
(en)
|
2009-08-20 |
2010-09-28 |
The Medicines Company |
Ready-to-use bivalirudin compositions
|
GB0915519D0
(en)
|
2009-09-04 |
2009-10-07 |
King S College London |
Ntithrombotic compounds
|
WO2011071799A2
(en)
|
2009-12-11 |
2011-06-16 |
Dr. Reddy's Laboratories Ltd. |
Purification of bivalirudin
|
US7985733B1
(en)
|
2010-01-06 |
2011-07-26 |
The Medicines Company |
Buffer-based method for preparing bivalirudin drug product
|
CN101906150B
(zh)
|
2010-06-28 |
2013-01-09 |
上海昂博生物技术有限公司 |
一种比法卢定的制备方法
|
EP2606060A1
(en)
|
2010-08-16 |
2013-06-26 |
CEM Corporation |
Water soluble solid phase peptide synthesis
|
KR20120069288A
(ko)
|
2010-12-20 |
2012-06-28 |
주식회사 씨트리 |
수용성 당 알코올을 이용한 비바리루딘의 정제방법
|
CN102260323A
(zh)
|
2011-05-30 |
2011-11-30 |
杭州诺泰制药技术有限公司 |
固相液相结合制备比伐卢定的方法和检测方法
|
WO2012165546A1
(ja)
|
2011-05-31 |
2012-12-06 |
味の素株式会社 |
ペプチドの製造方法
|
CN102286076B
(zh)
|
2011-06-23 |
2014-03-12 |
成都圣诺科技发展有限公司 |
比伐卢定的制备方法
|
CN102336813B
(zh)
|
2011-07-01 |
2016-01-06 |
上海苏豪逸明制药有限公司 |
一种固相多肽合成蛋白溶菌素的制备方法
|
US8906681B2
(en)
|
2011-08-02 |
2014-12-09 |
The Scripps Research Institute |
Reliable stabilization of N-linked polypeptide native states with enhanced aromatic sequons located in polypeptide tight turns
|
WO2013042129A1
(en)
|
2011-09-23 |
2013-03-28 |
Natco Pharma Limited |
Improved process for preparation of bivalirudin
|
CN102532274B
(zh)
|
2012-02-13 |
2014-04-23 |
成都圣诺生物制药有限公司 |
一种比伐卢定的制备方法
|
CN102641506B
(zh)
|
2012-04-11 |
2013-10-23 |
承德医学院中药研究所 |
比伐卢定-聚乙二醇化复合物
|
CN102731624B
(zh)
|
2012-06-14 |
2015-09-23 |
无锡市凯利药业有限公司 |
一种固相片段法合成比伐卢定的方法
|
CN102702325B
(zh)
|
2012-06-19 |
2015-09-23 |
深圳翰宇药业股份有限公司 |
一种抗凝血多肽的制备方法
|
CN102924575B
(zh)
|
2012-10-31 |
2014-12-31 |
深圳翰宇药业股份有限公司 |
一种比伐卢定的制备方法
|